Knight Therapeutics Inc. (GUD.TO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Knight Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -112.04x |
| P/B Ratio | 0.79x |
| P/S Ratio | 1.34x |
| Profitability | |
| Gross Margin | 33.5% |
| Operating Margin | -0.5% |
| Net Margin | -1.2% |
| EBITDA Margin | 12.1% |
| Liquidity | |
| Current Ratio | 2.39x |
| Quick Ratio | 1.57x |
| Leverage | |
| Debt/Equity | 0.10x |
YoY = year-over-year change. Source: FMP..